Skip to main content

Advertisement

Open Peer Review Reports for: A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial

Back to article

Pre-publication versions of this article are available by contacting editorial@trialsjournal.com.

Original Submission
14 May 2014 Submitted Original manuscript
14 May 2014 Author responded Author comments - Lars Pape
Resubmission - Version 2
14 May 2014 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
15 May 2014 Author responded Author comments - Lars Pape
Resubmission - Version 5
15 May 2014 Submitted Manuscript version 5
23 Jun 2014 Reviewed Reviewer Report - John Norrie
10 Jul 2014 Author responded Author comments - Lars Pape
Resubmission - Version 6
10 Jul 2014 Submitted Manuscript version 6
Publishing
4 Aug 2014 Editorially accepted
15 Aug 2014 Article published 10.1186/1745-6215-15-324

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement